XML 66 R59.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Earnings Per Share [Abstract]        
Net loss attributable to Adaptive Biotechnologies Corporation $ (32,071) $ (50,300) $ (125,800) $ (155,809)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 147,516,398 144,704,868 146,908,234 144,208,940
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.22) $ (0.35) $ (0.86) $ (1.08)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 147,516,398 144,704,868 146,908,234 144,208,940
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.22) $ (0.35) $ (0.86) $ (1.08)